Literature DB >> 20426058

A novel method for registration of US/MR of the liver based on the analysis of US dynamics.

Sergiy Milko1, Eivind Lyche Melvaer, Eigil Samset, Timor Kadir.   

Abstract

Radiofrequency ablation of liver cancer is a minimally invasive alternative to open surgery. Typically, the preoperative planning is done on an MR (or CT) scan, while the intervention relies on ultrasound (US) guidance. Registration of intra-operative US and preoperative MR (or CT) would assist navigation and increase the confidence of RFA needle positioning. In this paper we present a novel method for registration of US and MR images of the liver. Hepatic vessels are extracted from 2D US by an algorithm that models US dynamics. It generates 2D probability maps representing hepatic vessels which are then combined into probability volumes. A multi-resolution registration framework performs registration of the pre-processed MR with two 3D vessel probability images. The accuracy, robustness and speed of the method were assessed by registering eight US/MR datasets. High robustness (86%) and reasonable accuracy (1.98 degrees, 4.10 mm), acceptable for the RFA clinical application, suggest that the method has a good potential for intra-operative use.

Entities:  

Mesh:

Year:  2009        PMID: 20426058     DOI: 10.1007/978-3-642-04268-3_95

Source DB:  PubMed          Journal:  Med Image Comput Comput Assist Interv


  2 in total

1.  Geometric modeling of hepatic arteries in 3D ultrasound with unsupervised MRA fusion during liver interventions.

Authors:  Maxime Gérard; François Michaud; Alexandre Bigot; An Tang; Gilles Soulez; Samuel Kadoury
Journal:  Int J Comput Assist Radiol Surg       Date:  2017-03-07       Impact factor: 2.924

2.  Registration of 3D fetal neurosonography and MRI.

Authors:  Maria Kuklisova-Murgasova; Amalia Cifor; Raffaele Napolitano; Aris Papageorghiou; Gerardine Quaghebeur; Mary A Rutherford; Joseph V Hajnal; J Alison Noble; Julia A Schnabel
Journal:  Med Image Anal       Date:  2013-07-30       Impact factor: 8.545

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.